Spectral MD's DeepView Imaging Technology revolutionizing wound healing with Artificial Intelligence | News Direct

Spectral MD's DeepView Imaging Technology revolutionizing wound healing with Artificial Intelligence

News release by Spectral MD Holdings Ltd

facebook icon linkedin icon twitter icon pinterest icon email icon New York | July 05, 2023 05:37 PM Eastern Daylight Time

   

Spectral MD Holdings COO Niko Pagoulatos joined Proactive's Natalie Stoberman to share how the company plans to progress after receiving a recommendation for ISO 13485 certification.

Spectral MD develops technology using predictive analytics and AI algorithms to help clinicians make more accurate and faster treatment decisions. There are no diagnostic imaging devices that provide clinicians with an objective and immediate assessment of a wound’s healing potential.

Spectral MD’s DeepView Technology provides an informed solution for clinicians and allows for a clear picture of the wound to be established prior to treatment or other interventions. DeepView is a portable imaging platform that allows for immediate wound healing assessment and provides clinicians with physiological information that is not visible to the human eye.

 

Contact Details

 

Proactive USA

 

+1 347-449-0879

 

na-editorial@proactiveinvestors.com

Tags

ProactiveInvestorsSpectralMDWoundHealingAIinMedicineDeepViewTechnologyMedicalInnovationHealthcareTechnologyMedicalDevicesChronicWoundsAcuteWoundsBurnWoundCareDiabeticFootUlcersISO13485MultispectralImagingArtificialIntelligenceDigitalWoundAssessmentMedicalResearchInnovativeHealthcareAdvancedImagingMedicalCertificationPatientCareHealthTechTechnologyAdvancementsMedicalBreakthroughQualityStandardsCommercializationPlansMedicalIndustryinvestinvestinginvestmentinvestorstockmarketstocksstockstockmarketnews